Showing results (151-160 of 172) with videos related to
Sort By:
Pageof 18
Chemmedchem|February 26, 2013
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitorsMattia Mori, Cristina Tintori, Robert Selwyne Arul Christopher, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2004
Imbalance of osteoclastogenesis-regulating factors in patients with celiac diseaseAnna Taranta, Dario Fortunati, Maurizio Longo, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 14, 2007
A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclastsAndrea Del Fattore, Rachele Fornari, Liesbeth Van Wesenbeeck, et al.Journal of Medicinal Chemistry|June 11, 2013
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutantMarco Radi, Cristina Tintori, Francesca Musumeci, et al.The Journal of Biological Chemistry|January 14, 2016
Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring IsothiocyanateRoman Thaler, Antonio Maurizi, Paul Roschger, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 22, 2011
Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humansAnna Rufo, Andrea Del Fattore, Mattia Capulli, et al.Molecular Biology of the Cell|April 13, 2012
NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domainsRosa Angela Cardone, Maria Raffaella Greco, Mattia Capulli, et al.Bone|May 28, 2026
DPP3 deficiency impacts bone quality and sensitizes to metabolic alterationsEmilia Bevacqua, Valentina Granata, Daniele Panetta, et al.Biomedicines|March 25, 2022
The Pyrazolo[3,4-<i>d</i>]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of NeuroblastomaEnrico Rango, Fabio Pastorino, Chiara Brignole, et al.Journal of Medicinal Chemistry|December 4, 2014
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastomaCristina Tintori, Anna Lucia Fallacara, Marco Radi, et al.Pageof 18